The first combined vaccine against hepatitis A and B: an overview (Q77295189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

The first combined vaccine against hepatitis A and B: an overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1 reference

S Thoelen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P Van Damme

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Leentvaar-Kuypers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Leroux-Roels

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Bruguera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P C Frei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

V Bakasenas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Safary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

13-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1657-1662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Clinical trial with inactivated hepatitis A vaccine and recommendations for its use

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

1 reference

7 January 2021

Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Risk of viral hepatitis among military personnel assigned to US Navy ships

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Hepatitis B virus infection in hospital staff: epidemiology and persistence of vaccine-induced antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Prevalence of antibodies to hepatitis A virus in health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Increased risk for hepatitis A among female day nursery workers in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Risk factors for hepatitis A in day-care centers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

HBV infection in hemodialysis patients: monitoring and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900421-6

7 January 2021

10.1016/S0264-410X(98)00421-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194819%20AND%20SRC:MED&resulttype=core&format=json